切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2024, Vol. 12 ›› Issue (04) : 241 -244. doi: 10.3877/cma.j.issn.2095-655X.2024.04.005

病例诊断思维

冠心病合并类风湿关节炎患者PCI术后死亡一例
神童1, 申程1, 张艳艳2, 颜欣卓3, 甘立军1,()   
  1. 1.272029 济宁医学院附属医院心内科
    2.272029 济宁医学院附属医院入院与病员服务中心
    3.410220 长沙医学院第一临床学院
  • 收稿日期:2022-08-17 出版日期:2024-11-26
  • 通信作者: 甘立军
  • 基金资助:
    国家自然科学基金(82000269)济宁市重点研发计划(2020JKNS006)

One case of death in a patient with coronary heart disease complicated with rheumatoid arthritis after PCI

Tong Shen1, Cheng Shen1, Yanyan Zhang2, Xinzhuo Yan3, Lijun Gan1,()   

  1. 1.Department of Cardiology
    2.Admission and Patient Service Center,Affiliated Hospital of Jining Medical University,Jining 272029,China
    3.First Clinical College,Changsha Medical University,Changsha 410220,China
  • Received:2022-08-17 Published:2024-11-26
  • Corresponding author: Lijun Gan
引用本文:

神童, 申程, 张艳艳, 颜欣卓, 甘立军. 冠心病合并类风湿关节炎患者PCI术后死亡一例[J]. 中华诊断学电子杂志, 2024, 12(04): 241-244.

Tong Shen, Cheng Shen, Yanyan Zhang, Xinzhuo Yan, Lijun Gan. One case of death in a patient with coronary heart disease complicated with rheumatoid arthritis after PCI[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(04): 241-244.

目的

探讨冠心病合并类风湿关节炎(RA)患者经皮冠脉介入术(PCI)后支架内血栓形成的机制,以及PCI 的适应证及手术时机的选择。

方法

选择2021 年3 月5 日济宁医学院附属医院心内科收治的1 例冠心病合并RA 患者PCI 术后死亡病例的临床资料,并复习相关文献。

结果

患者既往RA 病史30 年,长期服用激素类药物,病情控制欠佳 ,近10 d 疼痛加重,既往冠心病病史10年,曾行PCI。抗环瓜氨酸肽抗体85.33 U/mL,类风湿因子66.6 U/mL,红细胞沉降率42 mm/h,C 反应蛋白17.4 mg/L,D-二聚体0.66 mg/L。2021 年3 月14 日,术前冠状动脉CT 提示冠状动脉狭窄。2021 年3 月16 日冠状动脉造影示:左前降支(LAD)近段狭窄90%,D1 开口狭窄95%。患者行PCI,于LAD 近段植入1 枚支架。术后30 min,患者感心前区剧烈疼痛,急诊冠脉造影示LAD 支架内血栓形成,心肌梗死溶栓试验前向血流0 级。经积极救治后,患者死亡。

结论

合并RA 急性期的冠心病患者PCI 后易形成支架内血栓,术前需充分评估适应证,并选择合适的时机。

Objective

To explore the mechanism of stent thrombosis after percutaneous coronary intervention (PCI) in a patient with coronary heart disease and rheumatoid arthritis (RA),and to explore the indications and timing of PCI.

Methods

The clinical data of a patient with coronary heart disease complicated with RA who died after PCI in the Department of Cardiology of the Affiliated Hospital of Jining Medical University on March 5,2021 were selected,and the relevant literature was reviewed.

Results

The patient had a 30-year history of RA,which was poorly controlled by long-term use of hormone drugs,and the pain worsened in the past 10 days.The patient had a 10-year history of coronary heart disease and underwent PCI.The anti-cyclic citrulline peptide antibody was 85.33 U/mL,rheumatoid factor 66.61 U/mL,erythrocyte sedimentation rate 42 mm/h,C-reactive protein 17.4 mg/L,and D-dimer 0.66 mg/L.On March 14,2021,preoperative coronary angiography showed acute stent thrombosis.On March 16,2021,coronary angiography showed 90% stenosis in the proximal segment of left anterior descending (LAD) and 95% stenosis in the opening of D1 branch.The patient underwent PCI and a stent was implanted in the proximal segment of the LAD.Thirty minutes after the operation,the patient felt severe pain in the precordial area.Emergency coronary angiography showed thrombosis in the LAD stent,and the thrombolysis in myocardial infarction flow grade was 0.After active treatment,the patient died.

Conclusions

Coronary heart disease patients with RA in the acute phase are prone to stent thrombosis after PCI.It is necessary to fully evaluate the indications and choose the appropriate time before PCI.

图1 类风湿关节炎合并冠心病患者冠状动脉造影图像 注:a 图为2021 年3 月16 日冠状动脉造影,左前降支近段狭窄90%,D1 支开口狭窄95%;b 图示于左前降支近段植入1枚支架;c 图2021 年3 月17 日冠状动脉造影,左前降支支架内血栓形成,前向血流TIMI 0 级;d 图示左回旋支血栓形成,血流中断(箭头所示)。TIMI 为心肌梗死溶栓试验
[1]
Li H,Sun K,Zhao R,et al.Inflammatory biomarkers of coronary heart disease[J].Front Biosci(Schol Ed),2018,10(1):185-196.DOI:10.2741/s508.
[2]
Ullrich H,Münzel T,Gori T.Coronary stent thrombosis-predictors and prevention[J].Dtsch Arztebl Int,2020,117(18):320-326.DOI:10.3238/arztebl.2020.0320.
[3]
Yuan S,Carter P,Mason AM,et al.Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk[J].Arthritis Rheumatol,2022,74(10):1638-1647.DOI:10.1002/art.42239.
[4]
Avina-Zubieta JA,Thomas J,Sadatsafavi M,et al.Risk of incident cardiovascular events in patients with rheumatoid arthritis:a metaanalysis of observational studies[J].Ann Rheum Dis,2012,71(9):1524-1529.DOI:10.1136/annrheumdis-2011-200726.
[5]
Rezuş E,Macovei LA,Burlui AM,et al.Ischemic heart disease and rheumatoid arthritis-two conditions,the same background[J].Life(Basel),2021,11(10):1042.DOI:10.3390/life11101042.
[6]
Zhang SQ,Niu QK,Tong L,et al.Identification of the susceptible genes and mechanism underlying the comorbid presence of coronary artery disease and rheumatoid arthritis: a network modularization analysis[J].BMC Genomics,2023,24(1):411.DOI:10.1186/s12864-023-09519-7.
[7]
Husarchuk AG,Ilashchuk TO,Okipniak IV,et al.Parameters of endothelial dysfunction and immune response in patients with rheumatoid arthritis with and without ischemic heart disease[J].Wiad Lek,2022,75(8 pt 2):1985-1990.DOI:10.36740.
[8]
Ketfi C,Boutigny A,Mohamedi N,et al.Risk of venous thromboembolism in rheumatoid arthritis[J].Joint Bone Spine,2021,88(3):105122.DOI:10.1016/j.jbspin.2020.105122.
[9]
Badimon L,Peña E,Arderiu G,et al.C-reactive protein in atherothrombosis and angiogenesis[J].Front Immunol,2018(9):430.DOI:10.3389/fimmu.2018.00430.
[10]
Singh AS,Atam V,Yathish BE,et al.Role of erythrocyte sedimentation rate in ischemic stroke as an inflammatory marker of carotid atherosclerosis[J].J Neurosci Rural Pract,2014,5(1):40-45.DOI:10.4103/0976-3147.127870.
[11]
赵宇航.类风湿性关节炎合并静脉血栓的危险因素分析[D].呼和浩特:内蒙古医科大学,2022.DOI:10.27231/d.cnki.gnmyc.2021.000162.
[12]
Xue L,Tao L,Li X,et al.Plasma fibrinogen,D-dimer,and fibrin degradation product as biomarkers of rheumatoid arthritis[J].Sci Rep,2021,11(1):16903.DOI:10.1038/s41598-021-96349-w.
[13]
Giannitsis E,Mair J,Christersson C,et al.How to use D-dimer in acute cardiovascular care[J].Eur Heart J Acute Cardiovasc Care,2017,6(1):69-80.DOI:10.1177/2048872615610870.
[14]
Keller K,Beule J,Balzer JO,et al.D-dimer and thrombus burden in acute pulmonary embolism[J].Am J Emerg Med,2018,36(9):1613-1618.DOI:10.1016/j.ajem.2018.01.048.
[15]
沈吉林,谢兴宇.大剂量糖皮质激素引起颅内静脉窦血栓形成1 例[J].中国现代医药杂志,2017,19(10):66-67.DOI:10.3969/j.issn.1672-9463.2017.10.022.
[16]
Kim SC,Solomon DH,Liu J,et al.Risk of venous thromboembolism in patients with rheumatoid arthritis:initiating disease-modifying antirheumatic drugs[J].Am J Med,2015,128(5):539.e7-e17.DOI:10.1016/j.amjmed.2014.11.025.
[1] 王博冉, 乔春梅, 李春歌, 王欣, 王晓磊. 超声造影评估类风湿关节炎亚临床滑膜炎疾病进展的价值[J]. 中华医学超声杂志(电子版), 2024, 21(08): 802-808.
[2] 王啸, 李一凡, 沈素红, 曹国瑞, 史小涛, 袁彦浩, 谭红略. 全膝关节置换术后早期下肢深静脉血栓形成的时空规律[J]. 中华关节外科杂志(电子版), 2024, 18(03): 414-420.
[3] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[4] 王敏, 周玲. 复发性流产的遗传因素病因学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 374-381.
[5] 杨城, 李祖儿, 刘青, 赵渊, 徐崇燕, 苏军, 张文云. 新型三维复合骨修复支架的制备工艺及其生物学性能[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 219-229.
[6] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[7] 李佳伟, 庞建智, 闫鹏宇, 卫阳兵, 杨晓峰. 术中输尿管识别技术研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 520-524.
[8] 杨文刚, 赖义明, 黄浩, 黄海. 斜跨位上下联通置入Allium覆膜输尿管支架治疗输尿管狭窄的初步经验[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 340-345.
[9] 方道成, 陈立新, 胡媛媛. 输尿管支架结壳的相关研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 402-405.
[10] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[11] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[12] 张家珺, 张海涛, 苏菲菲. 径向壁应变分析在冠心病诊疗中的应用[J]. 中华临床医师杂志(电子版), 2024, 18(07): 687-691.
[13] 魏贤杰, 黄河溯源, 张克石, 关振鹏. 山奈素通过抑制NF-κB减弱类风湿关节炎大鼠模型软骨细胞炎症及基质降解[J]. 中华临床医师杂志(电子版), 2024, 18(04): 375-382.
[14] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
[15] 唐欣, 翟文海, 王润婷, 周胜宇, 靳航. 补体在缺血性卒中疾病中的研究进展[J]. 中华脑血管病杂志(电子版), 2024, 18(04): 382-392.
阅读次数
全文


摘要